Therefore, we can assume that the balance between MDM2 and p53 mediates the tumor aggressiveness; as prior research similarly revealed, the downregulation of MDM2 in SW1990HM pancreatic adenocarcinoma cells increases levels of E-cadherin and decreases levels of matrix metallopeptidase 9 and Ki-67 [38]. The gene discussed is MDM2; the disease is pancreatic adenocarcinoma.